Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes Care

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.28.3.617PMID 15735198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction.

  2009cited by this paper
• Epidemiology of Diabetes

  2004cited by this paper
• Correlation between cardiovascular disease and diabetes mellitus: current concepts.

  2004cited by this paper
• Survival after myocardial infarction in patients with type 2 diabetes.

  2004cited by this paper
• Summary health statistics for U.S. adults: National Health Interview Survey, 2001.

  2004cited by this paper
• Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update.

  2004cited by this paper
• Medical evaluation and treatment of diabetic peripheral neuropathy.

  2003cited by this paper
• Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: the hoorn study.

  2003cited by this paper
• Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

  2003cited by this paper
• Optimal care of patients with type 2 diabetes mellitus and coronary artery disease.

  2003cited by this paper
• Diabetic foot ulcers.

  2003cited by this paper
• Microalbuminuria and clinical proteinuria as the main predictive factors of cardiovascular morbidity and mortality in patients with type 2 diabetes

  2003cited by this paper
• Microalbuminuria y proteinuria clínica como principales predictores de morbimortalidad cardiovascular en pacientes con diabetes tipo 2

  2003cited by this paper
• The antilipidemic effects of ezetimibe in patients with diabetes.

  2003cited by this paper
• [Microalbuminuria and clinical proteinuria as the main predictive factors of cardiovascular morbidity and mortality in patients with type 2 diabetes].

  2003cited by this paper
• Deaths: final data for 2001.

  2003cited by this paper
• Clinical and therapeutic aspects of diabetic nephropathy.

  2003cited by this paper
• The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men.

  2002cited by this paper
• Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study

  2002cited by this paper
• Dipstick proteinuria: can it guide hypertension management?

  2002cited by this paper
• Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes.

  2001cited by this paper
• Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes

  2001cited by this paper
• Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction.

  2001cited by this paper
• Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

  2001cited by this paper
• Microvascular complications. Retinopathy and nephropathy.

  2001cited by this paper
• Proteinuria and cardiovascular disease.

  2001cited by this paper
• High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy.

  2000cited by this paper
• Predictors of mortality and end‐stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy

  2000cited by this paper
• Relationship between diabetes and mortality: a population study using record linkage.

  2000cited by this paper
• The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.

  2000cited by this paper
• Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model.

  2000cited by this paper
• The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment?

  2000cited by this paper
• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000cited by this paper
• Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.

  1999cited by this paper
• Association of ocular disease and mortality in a diabetic population.

  1999cited by this paper
• [Prognosis after myocardial infarct in a diabetic patient: results of coronary intensive care unit epidemiological study].

  1998cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Diabetic cardiomyopathy

  1998cited by this paper
• Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

  1998cited by this paper
• Impact of Diabetes on Mortality After the First Myocardial Infarction

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes

  1997cited by this paper
• Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

  1997cited by this paper
• Increased Mortality Associated with Diabetic Foot Ulcer

  1996cited by this paper
• Blindness caused by diabetes--Massachusetts, 1987-1994.

  1996cited by this paper
• Relative mortality in lower limb amputees with diabetes mellitus

  1996cited by this paper
• Lower extremity foot ulcers and amputations in diabetes

  1995cited by this paper
• Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study

  1995cited by this paper
• Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group.

  1995cited by this paper
• Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in Diabetes

  1995cited by this paper
• Abnormal Albuminuria as a Predictor of Mortality and Renal Impairment in Chinese Patients With NIDDM

  1995cited by this paper
• The Relation of Diabetes to the Severity of Acute Myocardial Infarction and Post-Myocardial Infarction Survival in Mexican-Americans and Non-Hispanic Whites: The Corpus Christi Heart Project

  1994cited by this paper
• Mortality in diabetic patients after lower extremity amputations.

  1994cited by this paper
• A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDM

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Prognosis of Acute Myocardial Infarction in Diabetic and Non‐diabetic Patients

  1993cited by this paper
• C-peptide and the classification of diabetes mellitus patients in the Early Treatment Diabetic Retinopathy Study. Report number 6. The ETDRS Research Group.

  1993cited by this paper
• Mortality of Mexican Americans With NIDDM: Retinopathy and other predictors in Starr County, Texas

  1993cited by this paper
• The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective.

  1993cited by this paper
• Morbidity, Mortality, and Albuminuria in Type 2 Diabetic Patients: a Three‐year Prospective Study of a Random Cohort in General Practice

  1992cited by this paper
• Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM

  1992cited by this paper
• Frequency of recording of diabetes on U.S. death certificates: analysis of the 1986 National Mortality Followback Survey.

  1992cited by this paper
• Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

  1992cited by this paper
• Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography.

  1992cited by this paper
• Trends in Prevalence of Diabetes Mellitus in Patients with Myocardial Infarction and Effect of Diabetes on Survival: The Minnesota Heart Survey

  1991cited by this paper
• Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

  1991cited by this paper
• Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients.

  1990cited by this paper
• Microalbuminuria as predictor of increased mortality in elderly people.

  1990cited by this paper
• Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study.

  1989cited by this paper
• Diabetic cardiomyopathy.

  1989cited by this paper
• Microalbuminuria: A Major Risk Factor in Non‐insulin‐dependent Diabetes. A 10‐year Follow‐up Study of 503 Patients

  1988cited by this paper
• Long-Term Prognosis After Myocardial Infarction in Men with Diabetes

  1985cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper
• Mortality experience in the diabetic retinopathy study.

  1983cited by this paper
• Mortality experience in the diabetic retinopathy study.

  1983cited by this paper
• New visual acuity charts for clinical research.

  1982cited by this paper
• Morbidity and mortality in patients with diabetic retinopathy.

  1980cited by this paper
• Prognosis for life in patients with diabetes: relation to severity of retinopathy.

  1979cited by this paper
• THE MICROVASCULAR COMPLICAtions

  year unknowncited by this paper

• Physical Fitness, Biological Aging, and Healthy Longevity.

  2025cites this paper
• Nano‐Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type‐2 Diabetes Mellitus

  2025cites this paper
• Predictive models and determinants of mortality among T2DM patients in a tertiary hospital in Ghana, how do machine learning techniques perform?

  2025cites this paper
• Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia

  2025cites this paper
• From inflammation to intervention: exploring shared mechanisms and lifestyle strategies in diabetes mellitus and multiple sclerosis.

  2025cites this paper
• Diabetic retinopathy further increases risk of cardiovascular disease mortality in a high-risk cohort

  2025cites this paper
• Association of a body shape index with cardiovascular risk profile in subjects with type 2 diabetes mellitus: an observational hospital-based study

  2025cites this paper
• Improving clinical decision making by creating surrogate models from health technology assessment models: A case study on Type 1 Diabetes Melitus

  2025cites this paper
• Assessment of Hepatoprotective and Nephroprotective potentials of a Novel Anti-diabetic Poly Herbal Preparation

  2025cites this paper
• Differential Association of Salivary Proinflammatory Mediators with Type 2 Diabetes: A Network Meta-Analysis

  2024cites this paper
• Can artificial intelligence detect type 2 diabetes in women by evaluating the pectoral muscle on tomosynthesis: diagnostic study

  2024cites this paper
• Effect of highly sensitive C-reactive protein on cardiovascular risk of Type 2 diabetes mellitus adults: A systematic review

  2024cites this paper
• Validation of the Portuguese version of the diabetes self-management questionnaire-revised (DSMQ-R) in people with type 2 diabetes mellitus

  2024cites this paper
• Impact of social prescribing intervention on people with type 2 diabetes mellitus in a primary healthcare context: a systematic literature review of effectiveness

  2024cites this paper
• Unlocking the mechanistic potential of Thuja occidentalis for managing diabetic neuropathy and nephropathy

  2024cites this paper
• Cross-sectional associations of self-perceived stress and hair cortisol with metabolic outcomes and microvascular complications in type 2 diabetes

  2024cites this paper
• Novel gene-based therapeutic approaches for the management of hepatic complications in diabetes: Reviewing recent advances.

  2024cites this paper
• Natural Products as Pharmacological Modulators of Mitochondrial Dysfunctions for the Treatment of Diabetes and Its Complications: An update since 2010.

  2024cites this paper
• Review: Shilajit (Mumie) A natural Product with Anti-hyperglycemic, Anti-obesity, Anti-oxidant, and Anti-Inflammatory properties for a potential treatment of diabetes mellitus

  2024influential citation
• Predictive value of triglycerides to high-density lipoprotein cholesterol and triglyceride glycemic index for diabetes incidence in pre-diabetes patients: a prospective cohort study

  2023cites this paper
• Trends of clinical parameters and incidences of diabetes mellitus complications among patients with type 2 diabetes mellitus in Hong Kong, 2010–2019: a retrospective cohort study

  2023cites this paper
• Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

  2023cites this paper
• Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients—The Effect of Disease Duration

  2023cites this paper
• Meta-Analysis and Network Analysis Differentially Detect Various Pro-Inflammatory Mediators and Risk Factors for Type 2 Diabetes in the Elderly

  2023cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

  2023cites this paper
• The association between distal symmetric polyneuropathy in diabetes with all-cause mortality – a meta-analysis

  2023cites this paper
• Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy.

  2023cites this paper
• Association of High sensitivity C-reactive protein (Hs-CRP) with poor Glycaemic control and Coronary Heart Disease in Type 2 Diabetes Mellitus

  2023cites this paper
• Patient Experiences after Open Trigger Finger Release in Patients with Type 1 and Type 2 Diabetes—A Retrospective Study Using Patient-reported Outcome Measures

  2023cites this paper
• Multi-level Analysis of HbA1c in Diagnosis and Prognosis of Diabetic Patients.

  2023cites this paper
• Cumulative HbA1c exposure as a CVD risk in Patients with Type 2 Diabetes. A Post Hoc Analysis of ACCORD Trial.

  2023cites this paper
• Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus

  2022cites this paper
• Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008-2018.

  2022cites this paper
• The glucotoxicity protecting effect of honokiol in human hepatocytes via directly activating AMPK

  2022cites this paper
• Retinografia como forma de rastreio de retinopatia diabética em hospital terciário do Sistema Único de Saúde

  2022cites this paper
• Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis

  2022cites this paper
• Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly

  2022cites this paper
• The predictive value of resting heart rate in identifying undiagnosed diabetes in Korean adults: Korea National Health and Nutrition Examination Survey

  2022cites this paper
• Multi-level analysis reveals the association between diabetes, body mass index, and HbA1c in an Iraqi population

  2022cites this paper
• The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study

  2022cites this paper
• Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes.

  2022cites this paper
• Deep Personal Multitask Prediction of Diabetes Complication with Attentive Interactions Predicting Diabetes Complications by Multitask-Learning

  2022cites this paper
• Time-of-day moderate-to-vigorous physical activity and all-cause mortality in individuals with type 2 diabetes

  2021cites this paper
• Lifetime Cost-effectiveness of Oral Semaglutide Versus Dulaglutide and Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Oral Antidiabetics.

  2021cites this paper
• Micronutrients : A Potential Therapy For Diabetic Nephropathy And Cardiovascular Dysfunctioning-Molecular Basis

  2021cites this paper
• Covid 19 May Limit The Use of Anti-Hyperglycaemic Agents. Does It Call for The Development of New Anti-Hyperglycaemic Agents?

  2021cites this paper
• What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study

  2021cites this paper
• Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women

  2021cites this paper
• Utility Decrements Associated With Diabetes and Related Complications: Estimates From a Population-Based Study in Germany.

  2021cites this paper
• An Exploratory Screening Study for Type 2 Diabetes in Hospitalized Adult Medicine Patients.

  2021cites this paper
• Impact of Retinopathy and Systemic Vascular Comorbidities on All-Cause Mortality

  2021cites this paper
• Type 2 Diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Swedish Men and Women Older Than 55 Years

  2021cites this paper
• The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance.

  2021cites this paper
• Importance of Awareness and Treatment for Diabetes in Influenza Vaccination Coverage of Diabetic Patients under 65 Years: A Population-Based Study

  2020cites this paper
• A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management.

  2020cites this paper
• Identifying latent variables in Dynamic Bayesian Networks with bootstrapping applied to Type 2 Diabetes complication prediction

  2020cites this paper
• The Methodology for Diabetes Complications Prediction Model

  2020cites this paper
• Foot ulceration and its association with mortality in diabetes mellitus: a meta‐analysis

  2020cites this paper
• Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality.

  2020cites this paper
• University of Birmingham Obstructive sleep apnoea, a risk factor for cardiovascular and microvascular disease in patients with type 2 diabetes mellitus

  2020cites this paper
• Contents

  2020cites this paper
• Opening the black box: Personalizing type 2 diabetes patients based on their latent phenotype and temporal associated complication rules

  2020cites this paper
• Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort Study

  2020cites this paper
• Effects of platelet-rich plasma on the pancreatic islet survival and function, islet transplantation outcome and pancreatic pdx1 and insulin gene expression in streptozotocin-induced diabetic rats

  2020cites this paper
• The degree of retinopathy correlates with the presence of silent myocardial ischemia in diabetic patients

  2020cites this paper
• Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk strati cation

  2020cites this paper
• Predicting Type 2 Diabetes Complications and Personalising Patient Using Artificial Intelligence Methodology

  2020cites this paper
• Prevalence and risk profile of retinopathy in non‐diabetic subjects: National Health and Nutrition Examination Survey 2005 to 2008

  2019cites this paper
• Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification

  2019cites this paper
• University of Groningen Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease Rodriguez-Nino,

  2019cites this paper
• What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?

  2019cites this paper
• Patient and Health Care Factors Associated With Long-term Diabetes Complications Among Adults With and Without Mental Health and Substance Use Disorders

  2019cites this paper
• STATUS OF THE HUMORAL LINK OF IMMUNITY AT EXPERIMENTAL PERITONITIS ON THE BACKGROUND OF DIABETES MELLITUS

  2019cites this paper
• Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease

  2019cites this paper
• Comparison of Efficacy of Nortriptyline Versus Transcutaneous Electrical Nerve Stimulation on Painful Peripheral Neuropathy in Patients with Diabetes

  2019cites this paper
• REAL-TIME SENSING THE GLUCOSE CONCENTRATION BY QUADRATIC-SHAPED MICROWAVE SENSOR

  2019cites this paper
• Inflammatory markers and control of type 2 diabetes mellitus.

  2019cites this paper
• Weakness May Have a Causal Association With Early Mortality in Older Americans: A Matched Cohort Analysis.

  2019cites this paper
• Impact of Treating Oral Disease on Preventing Vascular Diseases: A Model-Based Cost-effectiveness Analysis of Periodontal Treatment Among Patients With Type 2 Diabetes

  2019cites this paper
• Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial.

  2019cites this paper
• Ganglion cell layer thickening in well‐controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?

  2019cites this paper
• The impact of sleep medications on physical activity among diabetic older adults.

  2019cites this paper
• Visual impairment and mortality in patients with type 2 diabetes

  2019cites this paper
• RAGE SIGNALING MEDIATES DEFICITS IN HIPPOCAMPAL FUNCTION IN MODELS OF DIABETES

  2019cites this paper
• In fl ammatory markers and control of type 2 diabetes mellitus

  2018cites this paper
• Glucose Aqueous Solution Sensingby Modified Hilbert Shaped Microwave Sensor

  2018cites this paper
• Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England

  2018cites this paper
• Nerve conduction velocity is negatively associated with intima-media thickness and brachial-ankle pulse wave velocity in men with type 2 diabetes mellitus

  2018cites this paper
• Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

  2018cites this paper
• DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT.

  2018cites this paper
• Renal dysfunction aggravated impaired cutaneous wound healing in diabetic mice

  2018cites this paper
• Presence of diabetic retinopathy is associated with worse 10‐year mortality among Indigenous Australians in Central Australia: The Central Australian ocular health study

  2018cites this paper
• Serum cathelicidin as a marker for diabetic nephropathy in patients with type 1 diabetes

  2018cites this paper
• Glucagon‐like peptide‐1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta‐analysis

  2018cites this paper
• Cost‐effectiveness analysis of real‐time continuous monitoring glucose compared to self‐monitoring of blood glucose for diabetes mellitus in Spain

  2018cites this paper
• Detection of carnosinase-1 in urine of healthy individuals and patients with type 2 diabetes: correlation with albuminuria and renal function

  2018cites this paper
• Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer

  2018cites this paper
• Nurse-led diabetic retinopathy screening: a pilot study to evaluate a new approach to vision care for Canadian Aboriginal peoples

  2018cites this paper
• Retinopathy.

  2018cites this paper
• Long-Term Mortality in Diabetic Patients with Tractional Retinal Detachments.

  2017cites this paper